Cefazolin high-inoculum effect in methicillin-susceptible staphylococcus aureus from south american hospitals

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 12, 2013, Pages 2773-2778

  Rincón, Sandra ^a   Reyes, Jinnethe ^a,b   Carvajal, Lina Paola ^a   Rojas, Natalia ^a   Cortés, Fabián ^a   Panesso, Diana ^a,b   Guzmán, Manuel ^c   Zurita, Jeannete ^d,e   Adachi, Javier A ^f   Murray, Barbara E ^b   Nannini, Esteban C ^g   Arias, Cesar A ^a,b  

^a UNIVERSIDAD EL BOSQUE   (Colombia)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Centro Medico Docente La Trinidad   (Venezuela)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

^e HOSPITAL VOZANDES   (Ecuador)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Bloodstream infections; Inoculum effect; Osteomyelitis

Indexed keywords

CEFAZOLIN; PENICILLIN DERIVATIVE;

ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; COLOMBIA; ECUADOR; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; MULTICENTER STUDY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OSTEOMYELITIS; PERU; PHENOTYPE; PREVALENCE; SOUTH AMERICA; SPECIES IDENTIFICATION; VENEZUELA;

BLOODSTREAM INFECTIONS; INOCULUM EFFECT; OSTEOMYELITIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFAZOLIN; COLOMBIA; ECUADOR; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84882363354     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt254     Document Type: Article

References (35)

1. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-71.
2. Bamberger DM, Boyd SE. Management of Staphylococcus aureus infections. Am Fam Physician 2005; 72: 2474-81.
3. Sabath LD. Reappraisal of the antistaphylococcal activities of firstgeneration (narrow-spectrum) and second-generation (expandedspectrum) cephalosporins. Antimicrob Agents Chemother 1989; 33: 407-11.
4. Nannini EC, Singh KV, Murray BE. Relapse of type A b-lactamaseproducing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis 2003; 37: 1194-8.
5. Zygmunt DJ, Stratton CW, Kernodle DS. Characterization of four b-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother 1992; 36: 440-5.
6. Kernodle DS, Stratton CW, McMurray LW et al. Differentiation of β-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis 1989; 159: 103-8.
7. Dyke KDH. β-Lactamases of Staphylococcus aureus. In: Hamilton-Miller JMT, Smith JT, eds. β-Lactamases. London: Academic Press, 1979; 291-310.
8. SorianoF,García-CorbeiraP, PonteCetal.Correlation of pharmacodynamic parameters of five b-lactam antibiotics with therapeutic efficacies in an animal model. Antimicrob Agents Chemother 1996; 40: 2686-90.
9. Brook I. Inoculum effect. Rev Infect Dis 1989; 11: 361-8.
10. Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of b-lactam antibiotics. Clin Infect Dis 1997; 24 Suppl 1: S19-45.
11. Nannini EC, Stryjewski ME, Singh KVet al. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother 2009; 53: 3437-41.
12. Fernández-Guerrero ML, de Gó rgolas M. Cefazolin therapy for Staphylococcus aureus bacteremia. Clin Infect Dis 2005; 41: 127.
13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI,Wayne, PA, USA, 2012.
14. LivorsiDJ, Crispell E,SatolaSWetal. Prevalenceof blaZgenetypesandthe inoculum effect with cefazolin among bloodstream isolates of methicillinsusceptible Staphylococcus aureus. Antimicrob Agents Chemother 2012; 56: 4474-7.
15. Rodriguez CA, Agudelo M, Zuluaga AF et al. In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin. BMC Infect Dis 2010; 10: 153.
16. Arias CA, Reyes J, Zúñiga M et al. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother 2003; 51: 59-68.
17. Reyes J, Rincón S, Díaz L et al. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis 2009; 15: 1861-7.
18. Martineau F, Picard FJ, Lansac N et al. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents and Chemother 2000; 44: 231-8.
19. Murray BE, Singh KV, Heath JD et al. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990; 28: 2059-63.
20. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of meticillin-resistant and meticillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
21. Voladri RK, Kernodle DS. Characterization of a chromosomal gene encoding type B b-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob Agents Chemother 1998; 42: 3163-8.
22. Lee S, Choe PG, Song KH et al. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? Antimicrob Agents Chemother 2011; 55: 5122-6.
23. Schweizer ML, Furuno JP, Harris AD et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011; 11: 279.
24. Stryjewski ME, Szczech LA, Benjamin DK Jr. Use of vancomycin or firstgeneration cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44: 190-6.
25. Quinn EL, Pohlod D, Madhavan Tet al. Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis. J Infect Dis 1973; 128 Suppl: S386-9.
26. Bryant RE, Alford RH. Unsuccessful treatment of staphylococcal endocarditis with cefazolin. JAMA 1977; 237: 569-70.
27. Shuford JA, Piper KE, Hein M et al. Lack of association of Staphylococcus aureus type A b-lactamase with cefazolin combined with antimicrobial spacer placement prosthetic joint infection treatment failure. Diagn Microbiol Infect Dis 2006; 54: 189-92.
28. East AK, Dyke KG. Cloning and sequence determination of six Staphylococcus aureus b-lactamases and their expression in Escherichia coli and Staphylococcus aureus. J Gen Microbiol 1989; 135: 1001-15.
29. Gillespie MT, Lyon BR, Skurray RA. Structural and evolutionary relationships of b-lactamase transposons from Staphylococcus aureus. J Gen Microbiol 1988; 134: 2857-66.
30. Barg N, Chambers H, Kernodle D. Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of b-lactamase. Antimicrob Agents Chemother 1991; 35: 1975-9.
31. Monecke S, Coombs G, Shore AC et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 2011; 6: e17936.
32. Cruz C, Moreno J, Renzoni A et al. Tracking methicillin-resistant Staphylococcus aureus clones in Colombian hospitals over 7 years (1996- 2003): emergence of a new dominant clone. Int J Antimicrob Agents 2005; 26: 457-62.
33. Rolo J, Miragaia M, Turlej-Rogacka A et al. High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One 2012; 7: e34768.
34. Vivoni AM, Diep BA, de Gouveia Magalhães AC et al. Clonal composition of Staphylococcus aureus isolates at a Brazilian university hospital: identification of international circulating lineages. J Clin Microbiol 2006; 44: 1686-91.
35. Enright MC, Robinson DA, Randle G et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002; 99: 7687-92.